The risk of peripartum cardiomyopathy (PPCM) is up to five times higher in mothers who undergo common fertility treatments like intracytoplasmic sperm injection (ICSI) and in vitro fertilization (IVF), according to data presented at Heart Failure 2019 in Athens.

Mental health disorders like PTSD and depression might not be as much of a barrier to cardiac rehabilitation as was previously thought, according to a study of more than 85,000 U.S. veterans published in the Journal of the American Heart Association.

Corindus Vascular Robotics’ CorPath GRX system—the world’s only FDA-approved and CE-marked robotic platform for percutaneous coronary intervention (PCI) and peripheral vascular intervention—was used in the first-ever live transmission of a robotic PCI in Europe during this year's EuroPCR congress.

Women are less likely to be resuscitated by bystanders than men in cases of out-of-hospital cardiac arrest, and when resuscitation is attempted they see lower survival rates, according to research published in the European Heart Journal May 21.

Three-year results of the BIO-RESORT study, presented at EuroPCR this week in Paris, put Biotronik’s ultrathin Orsiro stent ahead of two other competitors in terms of target lesion failure and revascularization.

An expert consensus document endorsed by four major cardiology societies redefines cardiogenic shock based on patient descriptions, physical markers and a standardized set of vocabulary.

Results from the FDA’s latest investigation into Abiomed’s Impella RP system are in—and, with a couple of caveats, they’re positive.

An absorbable, antibiotic-eluting mesh envelope significantly reduced the incidence of major cardiac implantable electronic device (CIED) infections in a recent study of nearly 7,000 patients, researchers reported in the New England Journal of Medicine May 16.